In conclusion, lnc‐GAS5 is correlated with higher susceptibility to AIS and greater inflammation and severity and could predict the risk of recurrence to some extent, indicating that monitoring of lnc‐GAS5 might improve the management of AIS. The gene discussed is GAS5; the disease is androgen insensitivity syndrome.